MedTrace Logo

Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter

NCT02591082 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2021-10-20

No results posted yet for this study

Summary

This is an observational study to assess patient survival and clinical outcomes after the RenovoCath™ RC120 catheter is used to deliver chemotherapeutic agents to pancreatic tumors.

Conditions

  • Pancreatic Neoplasms

Interventions

DEVICE

RenovoCath™ R120 Catheter

The RenovoCath™ RC120 Catheter will be used to isolate segments of arteries supplying blood to the pancreas. The two balloons on the catheter will be positioned and inflated to temporarily stop blood flow while medication is infused through the catheter between the balloons.

Sponsors & Collaborators

  • RenovoRx

    lead INDUSTRY

Principal Investigators

  • Ramtin Agah, MD · Chief Medical Officer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2021-02-26
Completion
2021-02-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02591082 on ClinicalTrials.gov